DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

CLSA Downgrades Dr Reddy's Laboratories to Outperform

CLSA analyst Alok Dalal downgrades Dr Reddy's Laboratories (NYSE:RDY) from Buy to Outperform.

Benzinga · 01/28/2020 11:47

CLSA analyst Alok Dalal downgrades Dr Reddy's Laboratories (NYSE:RDY) from Buy to Outperform.